KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Assets (2020 - 2025)

Organon has reported Assets over the past 6 years, most recently at $12.9 billion for Q4 2025.

  • Quarterly results put Assets at $12.9 billion for Q4 2025, down 1.79% from a year ago — trailing twelve months through Dec 2025 was $12.9 billion (down 1.79% YoY), and the annual figure for FY2025 was $12.9 billion, down 1.79%.
  • Assets for Q4 2025 was $12.9 billion at Organon, down from $13.6 billion in the prior quarter.
  • Over the last five years, Assets for OGN hit a ceiling of $13.6 billion in Q3 2025 and a floor of $9.6 billion in Q1 2021.
  • Median Assets over the past 5 years was $11.2 billion (2021), compared with a mean of $11.6 billion.
  • Biggest five-year swings in Assets: dropped 7.92% in 2022 and later grew 15.8% in 2024.
  • Organon's Assets stood at $10.7 billion in 2021, then rose by 2.57% to $11.0 billion in 2022, then grew by 10.07% to $12.1 billion in 2023, then increased by 8.65% to $13.1 billion in 2024, then decreased by 1.79% to $12.9 billion in 2025.
  • The last three reported values for Assets were $12.9 billion (Q4 2025), $13.6 billion (Q3 2025), and $13.5 billion (Q2 2025) per Business Quant data.